Literature DB >> 19631617

Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice.

Min-Juan Bian1, Li-Mei Li, Mei Yu, Jian Fei, Fang Huang.   

Abstract

IL-1beta is a potent pro-inflammatory cytokine that regulates neuroinflammation during brain damage. The expression of IL-1beta has been reported to be elevated in the striatum and substantia nigra of patients with Parkinson's disease (PD). Moreover, greater prevalence of PD in men than in women is described previously. Here, by using a sensitive mice model in which the expression of luciferase reporter gene is under the control of human IL-1beta gene promoter, we examined IL-1beta gene expression pattern in vivo after subacute MPTP toxication in old male and female mice and found that MPTP elicited greater dopaminergic toxicity in old male than in female mice. Old male mice showed dramatically elevated luciferase signals in a flexuous manner at early period of time, meanwhile, the changes in female were more moderate. However, no significant difference in astroglial reaction was observed at later time point between sexes. In conclusion, the present study demonstrated that elevated IL-1beta gene expression at early period of time may be in part responsible for the DA neuron susceptibility to MPTP in old male mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631617     DOI: 10.1016/j.brainres.2009.07.030

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

Review 2.  Microglial phenotypes in Parkinson's disease and animal models of the disease.

Authors:  Valerie Joers; Malú G Tansey; Giovanna Mulas; Anna R Carta
Journal:  Prog Neurobiol       Date:  2016-04-20       Impact factor: 11.685

Review 3.  The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-06-20       Impact factor: 5.590

4.  Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.

Authors:  Darcy Litteljohn; Emily Mangano; Melanie Clarke; Jessica Bobyn; Kerry Moloney; Shawn Hayley
Journal:  Parkinsons Dis       Date:  2010-12-30

Review 5.  Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease.

Authors:  Dongping Huang; Jing Xu; Jinghui Wang; Jiabin Tong; Xiaochen Bai; Heng Li; Zishan Wang; Yulu Huang; Yufei Wu; Mei Yu; Fang Huang
Journal:  Parkinsons Dis       Date:  2017-07-31

Review 6.  Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.

Authors:  Maria H Madeira; Raquel Boia; António F Ambrósio; Ana R Santiago
Journal:  Mediators Inflamm       Date:  2017-01-31       Impact factor: 4.711

Review 7.  Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.

Authors:  Ewelina Palasz; Wiktor Niewiadomski; Anna Gasiorowska; Adrianna Wysocka; Anna Stepniewska; Grazyna Niewiadomska
Journal:  Front Neurol       Date:  2019-11-01       Impact factor: 4.003

8.  Meta-type analysis of dopaminergic effects on gene expression in the neuroendocrine brain of female goldfish.

Authors:  Jason T Popesku; Christopher J Martyniuk; Vance L Trudeau
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-02       Impact factor: 5.555

9.  Bioluminescence imaging for IL-1β expression in experimental colitis.

Authors:  Limei Li; Zhenzhe Liu; Xinyu Yang; Huimin Yan; Shisan Bao; Jian Fei
Journal:  J Inflamm (Lond)       Date:  2013-04-11       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.